Drawing for DEATH STAR

USPTO serial 87006928

DEATH STAR

Reviewed by CopyMark Law Group

Status 605
Filing date
Status date
Registration date
—
Examiner
GRIFFIN, JAMES
Law office
GENERIC WEB UPDATE

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with DEATH STAR?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Bennet Langlotz

PO BOX 660675 #37585DALLAS, TX 75266UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
028TargetsABANDONEDMar 24, 2016

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 1, 2016MAB5ABANDONMENT NOTICE MAILED - AFTER PUBLICATION—
Sep 1, 2016ABN5ABANDONMENT - AFTER PUBLICATION—
Aug 29, 2016EXARTEAS EXPRESS ABANDONMENT RECEIVED—
Jul 7, 2016ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Jun 14, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 14, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 25, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 5, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 4, 2016DOCKASSIGNED TO EXAMINER—
Apr 25, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 23, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance